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Abstract 
 
This study determined the rate and indication for revision between cemented, 
uncemented, hybrid and resurfacing groups from NJR (6th Edition.) data. Data validity 
was determined by interrogating for episodes of misclassification. We identified 6,034 
(2.7%) misclassified episodes, containing 97 (4.3%) revisions. Kaplan-Meier revision 
rates at 3 years were 0.9% cemented, 1.9% for uncemented, 1.2% for hybrids and 
3.0% for resurfacings (significant difference across all groups, p<0.001, with identical 
pattern in patients <55 years). Regression analysis indicated both prosthesis group 
and age significantly influenced failure (p<0.001). Revision for pain, aseptic 
loosening, and malalignment were highest in uncemented and resurfacings. Revision 
for dislocation was highest in uncemented hips (significant difference between 
groups, p<0.001). Feedback to the NJR on data misclassification has been made for 
future analysis. 
 
Keywords: Joint Registry, hip arthroplasty, revision, indication. 
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Introduction. 
 
With the demographics of an ageing population, the number of hip replacements 
performed is set to rise by as much as 50% by 2026. Younger and more active 
patients with higher expectations will place higher demands on the prosthesis for a 
longer period of time increasing the likelihood of revision surgery. As a consequence 
revision hip surgery has increased by 100% due to implant failure since 19911 and 
figures from the American Academy of Orthopaedic Surgeons (AAOS) estimate that 
this rise will continue at a rate of 20-30% over the next three decades2 placing a huge 
burden on already limited resources. Careful monitoring of current practice and 
outcome is essential to determine the optimum strategy to resolving this emerging 
challenge. 
 
The National Joint Registry (NJR) of England and Wales was established in 2002 with 
an aim to define, improve and maintain the quality of care of individuals receiving hip, 
knee and ankle joint replacement surgery across the NHS and the independent 
healthcare sector3. Since its origin it has been collecting data and information on hip 
arthroplasty procedures. As the registry matures and the completeness of the data 
improves trends of current practice along with outcome have been established. At 
present with specific reference to revision procedures, the NJR reports revision rate by 
prosthesis group (categorised into cemented, uncemented, hybrid and resurfacing) 
along with the effect of age and gender on revision rates. However the reports 
currently do not include the cause of revision by prosthesis group. 
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Therefore utilising NJR primary hip data from the 6th Annual Report the aims of this 
study aimed to: 
1. Validate the available dataset by searching for areas of misclassification. 
2. Using the reclassified dataset, determine the revision rates of cemented, 
uncemented, hybrid and resurfacing prosthetic groups with comparison to those 
published in the 6th annual report. 
3. Determine and compare the revision rates by indication in each of the prosthetic 
groups both in patients of all ages and those less than 55years of age. s in revision 
rates  
4. Compare the revision rates between the most commonly used implants within each 
of the four prosthetic categories. 
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Materials & Methods 
 
Unlinked data from the NJR 6th annual report was obtained with permission from the 
NJR committee steering group and used for analysis. This database comprised of all 
primary hip procedures reported to the NJR between April 2003 and end of December 
2008. The grouping within the report into cemented, uncemented, hybrid and 
resurfacing is based on the field entitled “patient procedure type” within the NJR data 
collection forms. We therefore chose to validate the data by checking for 
misclassifications within this data field. An additional check for similar errors was also 
performed on the “missing data” cohort where no data was recorded in this field. From 
the reclassified database the following analysis was performed: 
1. Comparison of revision rates of all patients and those <55 years of age only, in 
each of the four prosthetic groups to the published rates from the NJR 6th Annual 
Report. 
2. Cox Regression analysis to identify the influence of gender and age on these 
revision rates and the relative risk of revision in uncemented, hybrid and resurfacing 
groups compared to the cemented group. 
3. Comparison of revision rate by cause using the indications for surgery recorded by 
the operating surgeon within the NJR data collection forms within each prosthetic 
group. Indications analysed included aseptic loosening of socket or stem, dislocation, 
infection, pain, malalignment and periprosthetic fracture (of socket or stem). The 
maximum length of follow up possible from the available data was chosen (ie 3 years) 
in line with the reported outcomes in the NJR Annual Report. 
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4. Subset analysis of these revision rates by indication with comparison according to 
the brand of component implanted using the five most commonly implanted cemented 
and uncemented and all resurfacing implants. 
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Results: 
 
Unlinked data was available on 222,895 primary hip procedures. Only cases linked to 
HES (Hospital episode statistics) and PEWS (Patient Episode Database for Wales) are 
reported in the annual reports and therefore are less in number (157,232 hip 
procedures published in 6th annual report4). Further breakdown of the proportion of 
cases within each prosthetic category is shown in Tables Ia and Ib. Linkage was 
commenced in 2006 to enable the collation and connection of all operations on a 
single patient. This was performed by “linking” patient information on NJR and HES 
records to allow confirmation of patient identity and determine the NHS number. 
Increasing the % of linked records allows more detailed analysis of data, with greater 
levels of confidence in its accuracy and conclusions. 
 
Misclassifications: Analysis of data integrity using patient procedure type identified 
6,034 episodes within the four primary and unclassified groups that were clearly 
misclassified –this included 3,017 in the cemented group, 984 in the uncemented 
group, 144 in the hybrid group, 1,847 in the resurfacing group, and 42 in the 
unclassified group. Furthermore within this misclassified cohort there were 97 revisions 
identified (60 revisions in cemented, 18 revisions in uncemented, 10 revisions in hybrid 
categories and 9 in the resurfacing group. 
 
Revision Rates: All patients- Using the reclassified database the Kaplan-Meier revision 
rates at 3 years were 0.9% (95%CI: 0.8% - 1.0%) for cemented prostheses, 1.9% 
(95%CI: 1.8% - 2.0%) for uncemented, 1.2% (95%CI: 1.0% - 1.4%) for hybrids and 
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3.0%, (95%CI: 2.7% - 3.3%) for resurfacing procedures. The trends in the revision 
rates were comparable to those published in the NJR 6th annual report4 and 
demonstrated significant differences across all groups (log rank p<0.001). For patients 
<55 years old, the Kaplan-Meier revision rates at 3 years (revision for any cause) were 
1.6% (95%CI: 1.0% - 2.2%) for cemented prostheses, 2.1% (95%CI: 1.7% - 2.5%) for 
uncemented, 1.6% (95%CI: 1.0% - 2.2%) for hybrids and 2.8%, (95%CI: 2.4% - 3.2%) 
for resurfacing procedures. The difference in the revision rates between either 
cemented or hybrid and uncemented or resurfacing cohorts was statistically significant 
(see table II for details). The Kaplan-Meier revision rates at 3 years for aseptic 
loosening only was lower in the cemented group (0.1%, 95%CI: 0.0% - 0.2%) than the 
uncemented group (0.3%, 95%CI: 0.1% - 0.5%) but did not reach full significance 
(p=0.07). 
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Table Ia: Original dataset obtained from the NJR, 6th Edition, with breakdown by age, 
sex, operated side, gender, ASA grade, and revision number, mean time to surgery 
and rate amongst each prosthetic group. 
 
ORIGINAL 
NJR 
DATASET 
 
Cemented 
 
Uncemented 
 
Hybrid 
 
Resurfacing 
 
Total 
 
Missing 
 
TOTAL 
n 92,757 66,197 29,473 18,267 206,694 14,203 220,897 
Start date 08/04/03 24/06/03 01/04/03 03/07/03    
Age (range) 
  Mean (SD) 
0.4 - 103.4 
72.7 (9.3) 
0 - 106.1 
65.3 (11.0) 
0 – 102.8 
68.6 (10.9) 
14.1 – 108.0 
55.1 (9.0) 
   
Side (R / L) 51,302 / 
41,455 
35,997 / 
30,200 
16,064 / 
13,409 
9578 / 8689    
Gender (M / 
F) 
32,050 / 
60,706 
28,392 / 
37,805 
11,174 / 
18,298 
11,822 / 
6445 
   
ASA grade 
  1 
  2 
  3 
  4 
  5 
 
14,223 
63,045 
14,798 
653 
38 
 
15,599 
42,902 
7362 
302 
32 
 
5411 
19,704 
4159 
182 
17 
 
8803 
8834 
600 
24 
6 
   
Revisions 
(%)* 
623 (0.67%) 808 (1.22%) 236 
(0.80%) 
383 (2.1%) 2,050 197 
(1.38%) 
2,247 
  Time yrs 
(SD) 
1.1 (1.0) 
4.2 
0.8 (0.8) 
3.7 
0.9 (0.9) 
3.2 
1.0 (1.0) 
3.8 
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Table Ib: Reclassified dataset obtained from the NJR, 6th Edition, with breakdown by 
age, sex, operated side, gender, ASA grade, and revision number, mean time to 
surgery and rate amongst each prosthetic group. 
 
Reclassified  Cemented Uncemented Hybrid Resurfacing Total Missing TOTAL 
n 97,294 69,981 31,755 21,369 220,399 496 220,885
Age (range) 
  Mean (SD) 
0.4 - 103.4 
73.0 (8.9) 
0 - 106.1 
65.3 (11.0) 
0 – 102.7 
68.7 (10.7) 
14.1 – 108.0 
54.8 (8.9) 
   
Side  
(R / L) 
53,945 / 
43,349 
38,087 / 
31,894 
17,290 / 
14,465 
11,193 / 
10,186 
   
Gender  
(M / F) 
33,012 / 
64,281 
30,054 / 
39,927 
11,853 / 
19,901 
14,010 / 
7359 
   
BMI (avail n) 
mean (SD) 
20,902 
28.4 (15.7) 
15,923 
29.5 (17.2) 
7235 
28.9 (16.1) 
4593 
28.7 (12.9) 
   
ASA grade 
  1 
  2 
  3 
  4 
  5 
 
14,777 
66,003 
15,745 
726 
43 
 
16,666 
45,227 
7733 
321 
34 
 
5897 
21,185 
4466 
189 
18 
 
10,431 
10,253 
654 
25 
6 
  
 
 
Revisions 
(%)* 
634 (0.7%) 869 (1.2%) 271 (0.9%) 466 (2.2%) 2240 (1.0%) 7 (1.4%) 2,247 (1.0%) 
  Time (yrs) 
(SD) 
1.2 (1.1) 
4.6 
0.9 (0.9) 
4.2 
1.0 (1.0) 
4.5 
1.1 (1.1) 
4.5 
ANOVA p<0.001* 
Revision 
rate @3yr 
 
(K-M)NJR 
0.9 
(0.8 – 1.0) 
 
1.3 
(1.2 – 1.4) 
1.9 
(1.8 – 2.0) 
 
2.8 
(2.6 – 3.0) 
1.2 
(1.0 – 1.4) 
 
1.9 
(1.7 – 2.1) 
3.0 
(2.7 – 3.3) 
 
4.5 
(4.0 – 5.0) 
Log rank p<0.001 
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Revision 
rate (K-M) 
under 55 
all reasons 
1.6 
(1.0 – 2.2) 
2.1 
(1.7 – 2.5) 
1.6 
(1.0 – 2.2) 
2.8 
(2.4 – 3.2) 
Log rank p<0.001 
Revision 
rate (K-M) 
under 55– 
ASL only 
0.1 
(0 – 0.2) 
0.3 
(0.1 – 0.5) 
0 0.3 
(0.1 – 0.5) 
Log rank p=0.03 
 
 
Cox Regression analysis: This showed that both age and prosthesis group in isolation 
had a significant influence on failure (p<0.001). After adjustment for the covariates age 
and gender, the relative risk of revision compared to the cemented group was 2.2x 
(RR=2.16, CI: 1.94-2.41) for uncemented hips, 1.4x (RR=1.41, CI: 1.22-1.63) for 
hybrid hips and 3.2x (RR=3.16, CI: 2.75-3.64) for resurfaced hips.  
 
Revision rates by indication (between groups): There was a significant differences in 
rates for pain, aseptic loosening, dislocation and malalignment between groups 
(p<0.001). Revision for pain, aseptic loosening and malalignment were highest in 
uncemented and resurfacing groups. Revision for dislocation was highest in the 
uncemented group. There was no significant difference in revision rates for lysis and 
infection between groups (p=0.57, p=0.514 respectively). Further details of % failures 
by indication in each group are outlined in Table II. 
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Table II: Number and percentage of failures by indication in each prosthesis group (p 
values represent differences between all groups with a significance level of 0.05). 
 
 Cemented (634) Uncemented (869) Hybrid (271) Resurfacing (466) P value 
Reasons for 
revn (%) 
Stem Socket Head Stem Socket Head Stem Socket Head Stem Socket Head  
Aseptic 
loosening 
69 
(0.07) 
107 
(0.11) 
 137 
(0.20) 
115 
(0.16) 
 19 
(0.06) 
49  
(0.15) 
 47 
(0.22) 
84  
(0.39) 
 p<0.001 stem 
p<0.001 socket
Implant # 5  
(0.005) 
1 
(0.001) 
2 
(0.002)
18 
(0.03) 
11 
(0.02) 
7  
(0.01) 
3  
(0.01) 
2  
(0.01) 
0 13 
(0.06) 
1  
(0.005) 
13  
(0.06) 
-- 
Mismatch 4 
(0.004) 
4 
(0.004) 
 8  
(0.01) 
7  
(0.01) 
 3  
(0.01) 
3  
(0.01) 
 4  
(0.02) 
4  
(0.02) 
 -- 
Lysis 21 
(0.02) 
25 
(0.03) 
 19 
(0.03) 
12 
(0.02) 
 7  
(0.02) 
8  
(0.03) 
 8  
(0.04) 
10  
(0.05) 
 p<0.57 
Malalignment 20 
(0.02) 
52 
(0.05) 
 42 
(0.06) 
97 
(0.14) 
 12 
(0.04) 
36 
(0.11) 
 6  
(0.03) 
38  
(0.18) 
 p<0.001 stem 
p=0.037 socket
Peripros # 33 
(0.03) 
8 
(0.008) 
 120 
(0.17) 
12 
(0.02) 
 21 
(0.07) 
7  
0.02) 
 103 
(0.48) 
7  
(0.03) 
 p<0.001 stem 
p<0.037 socket
Dislocation 197 (0.20) 225 (0.32) 96 (0.30) 28 (0.13) p<0.001 
Infection 189 (0.19) 131 (0.19) 54 (0.17) 32 (0.15) p=0.514 
Pain 80 (0.08) 129 (0.18) 28 (0.09) 117 (0.55) p<0.001 
Poly wear 3 (0.003) 18 (0.03) 4 (0.01) 6 (0.03) -- 
Dissociation 
liner 
2 (0.002) 13 (0.02) 6 (0.02) 3 (0.01) -- 
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Revision rates by indication (between prosthetic brand): The revision rates for all causes 
in the five most common brands ranged from 0.22% – 0.72% for cemented implants, 0.97% - 
1.46% for uncemented implants and 1.69 – 3.46% for resurfacings. (Further breakdown by 
indication is shown in Tables III,IV and V). 
 
Table III: Revision rates by indication for the most implanted cemented femoral stems. 
 
 
 
  Aseptic 
loosening 
Lysis  Dislocation  Infection  Peri 
pros #  
Pain  Malalignment  TOTAL  Rate
Exeter  25  11  96  81  17  41  11  303/50,225 0.60 
Charnley  23  4  24  39  1  15  0  95/13,171  0.72 
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Table IV: Revision rates by indication for the most implanted uncemented femoral stems. 
 
  Aseptic 
loosening 
Lysis  Dislocation  Infection Peri 
pros # 
Pain  Malalignment  Total  Rate
Corail  35  3  80  47  35  43  14  277/26,286 1.05 
Furlong 
HAC 
27  3  48  16  19  21  7  171/13,219 1.29 
SL‐Plus  14  3  17  13  5  8  3  58/3972  1.46 
Accolade  8  0  9  5  10  15  1  49/4235  1.16 
Taperloc  7  1  11  7  4  1  0  31/3207  0.97 
 
C‐Stem  4  2  20  14  4  7  1  50/7839  0.64 
CPT  2  1  17  12  4  4  3  43/6144  0.70 
C‐stem 
AMT 
0  0  1  2  0  0  0  4/1799  0.22 
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Table V: Revision rates by indication for resurfacing hip implants. 
  Aseptic 
loosening 
Lysis  Dislocation  Infection Peri 
pros # 
Pain  Malalignment  Total  Rate
BHR  21  3  15  13  49  46  4  211/11,265 1.87 
Cormet  7  2  4  6  6  17  1  58/2451  2.37 
ASR  6  1  3  7  17  29  0  84/2427  3.46 
Adept  2  1  2  2  10  8  0  26/1542  1.69 
Durom  4  1  1  2  5  7  0  35/1202  2.91 
Conserve  5  0  3  0  6  5  1  27/732  3.69 
Recap  0  0  0  1  8  0  0  13/854  1.52 
Mitch  0  0  0  0  1  1  0  4/252  1.59 
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Discussion: 
 
Linkage of data recorded within the NJR to additional databases was introduced in 
2006 in order to augment accuracy and capture of data5. In the latest report it was 
reported that the overall capture of data had improved from 53% in the fourth annual 
report to 69%6 in the 6th annual report4. However despite these processes being 
instituted, this study has highlighted simple areas of misclassification that can be 
easily rectified to allow more accurate interpretation of the data. Although these 
misclassification rates are relatively low, they are a source of bias that can be easily 
rectified. As the Registry matures comprehensive acquisition of data is the goal and 
careful analysis for data accuracy must be carried out to protect the validity and power 
of future extracted data. 
 
Revision rates by fixation: Data of prosthesis sales within the UK4, as well as from the 
latest NJR report (7th edition)7 has demonstrated that the current trend on implant use 
continues to favour uncemented technology with an overall increase in the number of 
uncemented components being implanted each year (22% in 2005 to 39% in 2009) 
whilst the use of cemented implants has declined (54% in 2005 to 34% in 2009). This 
continues despite Register data reported from Sweden8, Australia9 and the UK7 NJR 
that has shown inferior results (for revision for any cause in all ages of patients) with 
uncemented THA. The exact reason for this trend remains uncertain but proposed 
factors in justification of uncemented THA include a potentially shorter operation time, 
avoidance of the perceived adverse effects of bone cement and claims of bone 
preservation. 
18 
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In the younger more active patient however the message is less clear with opposing 
evidence between registries on beneficial outcome with uncemented THA10-12. Data 
from the New Zealand12,13 and Finnish Joint Registries14 has showed superior 
outcome of uncemented arthroplasty in younger patients in contrast to the Swedish 
Registry14 which has showed inferior results. 
 
Concerns over higher rates of early aseptic loosening in the young active patient with 
cemented components are often proposed as a reason for selecting an uncemented 
component. Greater potential of implant integration into younger host bone has been 
used as an argument for uncemented fixation15. This study based on UK data 
demonstrates inferior results with the use of uncemented implants with an overall 
higher revision rate not only for failure for any cause but also for aseptic loosening 
only. 
 
Independent of method of implant fixation regression analysis confirmed the significant 
effect that age continues to have on revision rates. The Swedish hip Arthroplasty 
Register had showed the average age of patients undergoing primary THA is slowly 
declining16. However, in the latest edition of the NJR annual report, the percentage of 
those under 55 years of age undergoing THA was reported as having remaining static 
since 20037. This is reassuring given that young patients continues to do less well than 
older patients in terms of implant survivorship despite new developments with bearing 
surfaces and prosthesis design. 
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Revision rates by indication: The predominant cause of revision in hip arthroplasty in 
the UK continues to be secondary to aseptic loosening involving 49% of the overall 
revision burden. This observation has also been observed in the Australian (29.9%), 
Swedish (63.3%)16 and Norweigan (44.8%)17 and Finnish (65%)18 registries. The 
development of uncemented and later alternative bearings (including metal on metal 
with hip resurfacing) to conventional polyethylene, were introduced with the proposed 
advantage of reducing this rate. In this series breakdown by fixation however still 
demonstrated the higher rate of aseptic loosening in the uncemented and resurfacing 
groups. When analysing the <55 cohort, the rate of aseptic loosening still remained 
lowest in the cemented cohort. Without a breakdown of the various bearing surfaces 
used in the uncemented cohort (in particular the number of uncrosslinked polyethylene 
liners implanted), the true significance of these findings is limited. We also 
acknowledge that the length of follow up is short. As a result it is more difficult to 
establish the validity of these rates as surgical factors and technique that can often 
play a part in early failure may account for some of the difference irrespective of the 
method of fixation or prosthesis used. 
 
Revision for malalignment was also highest in the uncemented and resurfacing 
groups. Component position has now been shown to be integral and very sensitive 
(varies between prostheses) to the outcome of hip resurfacings10,19. In particular a high 
inclination angle leading to edge loading has been linked with increased metal ion 
levels and subsequent adverse reaction to metal debris (ARMD) with an overall 
increased rate of failure. Langton et al21 have demonstrated high early failure rates 
with the ASR device which has also been shown to have a very narrow range for 
component position for optimum function and outcome. Data from the NJR has 
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confirmed this to a nationwide finding with the ASR having the highest revision rate 
amongst the resurfacing implants7. This has prompted the recent MHRA alert with 
retraction of this implant from the market and highlights one of the key important 
attributes in having a national joint registry.  
 
The high incidence of unexplained pain in 117 out of the 466 (25%) of all metal on 
metal hip resurfacing remains a concern. Comparison to the Australian joint registries 
showed a much lower rate with only 5.3% of resurfacing revisions being performed for 
unexplained pain with the leading cause of revision being due to fracture or aseptic 
loosening9. The indications for revisions however are different between registries. 
There are unique modes of failure in metal on metal arthroplasties including metal 
hypersensitivity, metallosis, pseudotumours and ALVAL (encompassed by the 
umbrella term Adverse reaction to metal debris, ARMD) which are often associated 
with symptoms22,23 and are not available as options on the UK NJR revision form but 
are part of the Australian data collection. These novel diagnoses which cover a 
spectrum of both radiological and histological findings have resulted in a greater 
variability in diagnosis between centres which further affect the category under which 
these revision cases are entered. These factors may explain the variation of rates of 
revision by cause between registries. Consensus on diagnosis and data collection is 
required before comparisons of revision rate by cause in metal on metal resurfacing 
between registries can be made. 
 
Comparison between THA groups revealed revision for pain was also higher in the 
uncemented cohort. The incidence of recalcitrant thigh pain with cementless designs 
ranges from 0.5% to 40%24. Most published series show that only a small percentage 
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(<4%) of patients experience severe, disabling pain25. In this series the rate of revision 
for pain in the uncemented group was 0.18%. In these cases further breakdown of 
data on the socket and stem would further elucidate (if any) a primary source of 
recalcitrant symptoms. The low rate of pain again seen in the hybrid cohort would 
suggest that the uncemented stem is the predominant factor responsible for these 
findings. 
 
The incidence of periprosthetic fracture was highest for the uncemented stem (120 out 
of 869, incidence of 0.17%) and resurfacing femoral component. The higher incidence 
of periprosthetic fracture is a recognised complication of using an uncemented stem26 
that appears to currently be borne out in current national practice. 
 
Revision for dislocation was highest for the uncemented group. Dislocation is 
multifactorial in nature with causes commonly divided up into surgical, patient and 
implant related factors. Malalignment is a recognised risk factor within the surgical 
subset and as discussed earlier was also higher in the uncemented compared to 
cemented group. Data from the Australian joint registry concerning dislocation shows 
similar findings to the UK NJR27. 
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CONCLUSION 
 
The overall aims of a National Joint Registry are to pool data, recognise trends, 
improve the quality of THA and promote evidence based surgical practice. This study 
has highlighted the importance of scrutinising individual fields within the category 
subsets to prevent misclassification of data and maximise the validity of the NJR 
database. Comparison between registries has been limited due to variation in key 
features presented within national reports. To allow unbiased comparisons, these 
need to be clearly defined and internationally agreed. 
Several important trends have been highlighted by this study: 
1. The use of uncemented implants is increasing despite higher revision rates when 
compared to cemented and hybrid prostheses. 
2. Cement and hybrid implants continue to function well in all age groups including 
those under 55 years of age. 
3. Contributory factors to poorer implant survival in the uncemented group include an 
increased incidence of pain, malalignment and periprosthetic fracture of the stem. 
4. The importance of component positioning in hip resurfacing is further highlighted by 
high failure rates secondary to malalignment. High rates of revision for unexplained 
pain raises further concerns over the safe use of metal on metal articulations.  
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